NEWS
GSK sues Moderna for US patent infringement over COVID, RSV vaccines
Published On :
By Blake Brittain
(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster COVID-19 vaccine Spikevax and RSV shot mResvia.
According to the two lawsuits, Moderna’s lipid nanoparticles for transporting fragile mRNA into the human body infringe several GSK patents covering similar innovations. GSK filed a related lawsuit against Pfizer and BioNTech in the same court in April over their COVID-19 vaccine. The new litigation seeks unspecified monetary damages.
A spokesperson for Massachusetts-based Moderna said the company was aware of the lawsuits and would defend itself against the claims.
GSK is “willing to license these patents on commercially reasonable terms and to ensure continued patient access,” a company spokesperson said.
The lawsuits add to a web of U.S. court cases involving Pfizer, BioNTech and Moderna over patent royalties for technology used in their COVID vaccines, including one brought by Moderna against Pfizer in 2022.
Moderna earned $6.7 billion in revenue from Spikevax last year. Pfizer made $11.2 billion from sales of Comirnaty, the COVID vaccine it developed with German partner BioNTech. Sales of both vaccines declined significantly last year from 2022.
GSK also sued Pfizer for patent infringement over its RSV shot Abrysvo last year. The U.S. Food and Drug Administration approved Moderna’s RSV vaccine in May.
GSK said in the new cases that its patents cover technology pioneered in 2008 that provides “the foundation for Moderna’s mRNA vaccine portfolio.” GSK said it bought the rights to the inventions when it acquired part of Novartis’ vaccine business in 2015.
(Reporting by Blake BrittainEditing by David Bario, Will Dunham and Bill Berkrot)
Uma Rajagopal has been managing the posting of content for multiple platforms since 2021, including Global Banking & Finance Review, Asset Digest, Biz Dispatch, Blockchain Tribune, Business Express, Brands Journal, Companies Digest, Economy Standard, Entrepreneur Tribune, Finance Digest, Fintech Herald, Global Islamic Finance Magazine, International Releases, Online World News, Luxury Adviser, Palmbay Herald, Startup Observer, Technology Dispatch, Trading Herald, and Wealth Tribune. Her role ensures that content is published accurately and efficiently across these diverse publications.
-
-
FINANCE4 days ago
Sterling extends bounce off recent lows as U.S. election in focus
-
-
-
BUSINESS4 days ago
China EV price deal needs be as effective as tariffs, says EU official
-
-
-
NEWS3 days ago
KPMG to lay off less than 4% of US audit workforce, source says
-
-
-
NEWS3 days ago
Shein’s European entity reports 68% sales growth in 2023
-